Abstract
Protein A has long been the ligand of choice in the affinity purification of immunoglobulin G1 (IgG1) monoclonal antibodies (see Notes 1 and 2). However, current research efforts (1–9) have been focused on the discovery of small molecules (peptides or peptidomimetics) that share similar binding characteristics with protein A but are more cost effective owing to small size (for ease of synthesis) and stability (for ease of regeneration). The following methods were developed as part of a proof of principle study (1) to determine whether phage display technology could be used to identify peptides as leads in the customization of ligands for affinity chromatography (see Note 3) and (2) to identify a peptide or peptidomimetic for use as a protein A alternative in the affinity purification of monoclonal antibodies. In this study, the constant region (pFc’ fragments; see Note 4) of an IgG1 monoclonal antibody, denoted humanized anti-Tac (HAT), was used as the target for phage display in this study. HAT is a humanized monoclonal antibody against the low-affinity p55 subunit of the interleukin-2 (IL-2) receptor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Braisted A. C. and Wells J. A. (1996) Minimizing a binding domain from protein A. Proc. Natl. Acad. Sci USA 93, 5688–5692.
Li R., Dowd V., Stewart D. J., Burton S. J., and Lowe C. R. (1998) Design, synthesis, and application of a protein A mimetic. Nat. Biotechnol. 16, 190–195.
Fassina G., Verdoliva A., Palombo G., Ruvo M., and Cassini G. (1998) Immunoglobulins specificity of TG1 9318: a novel synthetic ligand for antibody affinity purification. J. Molec. Recogn. 11, 12–133.
Guerrier L, Flayeux I., Schwarz A., Fassina G. and Boschetti E. (1998) IRIS: an innovative protein A-peptidomimetic solid phase medium for antibody purification. J. Molec. Recogn. 11, 107–109.
Palombo G., DeFalco S., Tortora G., Cassani G., and Fassina G. (1998) A synthetic ligand for IgA affinity purification. J. Molec. Recogn. 11, 243–246.
Palombo G., Rossi M., Cassani G., and Fassina G. (1998) Affinity purification of mouse monoclonal IgE using a protein A mimetic ligand [TG19318] immobilized on solid supports. J. Molec. Recogn. 11, 247–249.
Palombo G., Verdoliva A., and Fassina G (1998) Affinity purification of immu-noglobulin M using a novel synthetic ligand. J. Chromatogr. B Biomed. Sci. Appl. 715, 137–145.
Ehrlich G. K. and Bailon P. (1998) Identification of peptides that bind to the constant region of a humanized IgG1 monoclonal antibody using phage display. J. Molec. Recogn. 11, 121–125.
Sengupta J., Sinha P., Mukhopadhyay C., and Ray P. K. (1999) Molecular modeling and experimental approaches toward designing a minimalist protein having Fc-binding activity of Staphylococcal protein A. Biochem. Biophys. Res. Commun. 256, 6–12.
Queen C., Schneider W. P., Selick H. E., Payne P. W., Landolfi N., Duncan J.F., Avdalovic N. M., Levitt M., Junghans R. P., and Waldman T. A. (1989) A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86, 10,029–10,033.
Junghans R. P., Waldman T. A., Landolfi N. F., Avdalovic N. M., Schneider W. P., and Queen C. (1990) Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res. 50, 1495–1502.
Bailon P., Weber D. V., Keeney R. F., Fredericks J. E., Smith C., Familletti P. C., and Smart J. E. (1987) Receptor-affinity chromatography: A one-step purification for recombinant interleukin-2. Bio/Technology 5, 1195–1198.
Bailon P. and Weber D. V. (1988) Receptor-affinity chromatography. Nature (London) 335, 839–840.
Hakimi J., Seals C., Anderson L. E., Podlaski F. J., Lin P., Danho W., Jenson J. S., Perkins A., Donadio P. E., Familletti P. C., Pan Y-C.E., Tsien W.-H., Chizzonite R. A., Casabo L., Nelson D. L., and Cullen B. R. (1987) Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. J. Biol. Chem. 262, 17,336–17,341.
Weber D. V., Keeney R. F., Familletti P. C., and Bailon P. (1988) Medium-scale ligand-affinity purification of two soluble forms of human interleukin-2 receptor. J. Chrom. Biomed. Appl. 431, 55–63.
Uhlen M., Guss B., Nilsson B., Gatenbeck S., Philipson L., and Lindberg M. (1984) Complete sequence of the Staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J. Biol. Chem. 259, 1695–1702.
Nilsson B., Moks T., Jansson B., Abrahmseen L., Elmblad A., Holmgren E., Herichson C., Jones T. A., and Uhlen M. (1987) A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1, 107–113.
Maclennan J. (1997) The generation of process suitable, rugged, targeted affinity ligands using phage display technology. Twelfth Sympsium on Affinity Interactions: Fundamentals and Applications of Biomolecular Recognition. Abstract L30.
Torigoe H., Shimada I., Waelchli M., Saito A., Sato M., and Arata Y. (1990) 15N nuclear magnetic resonance studies of the B domain of staphylococcal protein A: sequence specific assignments of the imide 15N resonances of the proline residues and the interaction with human immunoglobulin G. FEBS Lett. 269, 174–176.
Torigoe H., Shimada I., Saito A., Sato M., and Arata Y. (1990) Sequential 1H NMR assignments and secondary structure of the B domain of staphylococcal protein A: structural changes between the free B domain in solution and the Fc-boundB domain in crystal. Biochemistry. 29, 8787–8793.
Gouda H., Torigoe H., Saito A., Sato M., Arata Y., and Shimada I. (1992) Three-dimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures. Biochemistry 31, 9665–9672.
Jendeberg L., Tashiro M., Tejero R., Lyons B. A., Uhlen M., Montelione G. T., and Nilsson B. (1996) The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding. Biochemistry 35, 22–31.
Lyons B. A., Tashiro M., Cedergren L., Nilsson B., and Montelione G. T. (1993) An improved strategy for determining resonance assignments for isotopi-cally enriched proteins and its application to an engineered domain of staphylococcal protein A. Biochemistry 32, 7839–7845.
Tashiro M. and Montelione G. T. (1995) Structures of bacterial immunoglobu-lin-binding domains and their complexes with immunoglobulins. Curr. Opin. Struct. Biol. 5, 471–481.
McDowell R. S., Blackburn B. K., Gadek T. R., McGee L. R., Rawson T., Reynolds M. E., Robarge K. D., Somers T. C., Thorsett E. D., Tischler M., Webb R. R., and Venuti M. C. (1994) From peptide to non-peptide. 2. The de novo design of potent, non-peptidal inhibitors of platelet aggregation based on a benzodiazepine scaffold. J. Am. Chem. Soc. 116, 5077–5083.
Ley C. A. (1997) Custom affinity ligands from phage display for large-scale affinity purification. IBC International Conference on Display Technologies. Lake Tahoe, CA.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Ehrlich, G.K., Bailon, P., Berthold, W. (2000). Phage Display Technology. In: Bailon, P., Ehrlich, G.K., Fung, WJ., Berthold, W. (eds) Affinity Chromatography. Methods in Molecular Biology, vol 147. Humana Press. https://doi.org/10.1007/978-1-60327-261-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-60327-261-2_19
Publisher Name: Humana Press
Print ISBN: 978-0-89603-694-9
Online ISBN: 978-1-60327-261-2
eBook Packages: Springer Protocols